TriSalus Life Sciences (TLSI) Other Non-Current Assets (2022 - 2026)

TriSalus Life Sciences' Other Non-Current Assets history runs 5 years deep, the most recent figure standing at $69000.0 for Q1 2026.

• On a quarterly basis, Other Non-Current Assets fell 83.73% year-over-year to $69000.0 in Q1 2026; TTM through Mar 2026 was $69000.0, a 83.73% decrease from a year earlier, with the FY2025 full-year figure at $418000.0, down 1.18% from the prior year.
• Other Non-Current Assets fell to $69000.0 in Q1 2026 per TLSI's latest filing, from $418000.0 in the prior quarter.
• Across five years, Other Non-Current Assets topped out at $466000.0 in Q4 2023 and bottomed at $69000.0 in Q1 2026.
• The 5-year median for Other Non-Current Assets is $421000.0 (2024), against an average of $387000.0.
• Across the five-year window, Other Non-Current Assets grew 26.98% in 2023 and slumped 83.73% in 2026, its largest moves.
• Year by year, Other Non-Current Assets stood at $367000.0 in 2022, then gained by 26.98% to $466000.0 in 2023, then slipped by 9.23% to $423000.0 in 2024, then slipped by 1.18% to $418000.0 in 2025, then plunged by 83.49% to $69000.0 in 2026.
• Per Business Quant, the three latest TLSI Other Non-Current Assets figures stand at $69000.0 (Q1 2026), $418000.0 (Q4 2025), and $419000.0 (Q3 2025).